USC’s Keck Medicine is conducting a new research to see if immunotherapy administered at home is equally effective as in a hospital. The treatment goal of...
The immunotherapy drug, durvalumab, has been the norm of care for patients with stage III non-little cell lung cancer(NSCLC) to further develop endurance, when recommended after...
The expansion of growth getting fields chemotherapy didn’t delay endurance for ladies with platinum-safe ovarian disease, as per the gadget’s maker. Growth treating fields [TTFields (Novocure)]...
Two genes, NEK2 and INHBA, have been found to be the root of chemotherapy resistance in patients with head and neck cancer. Surprisingly, cancer cells that...
